Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
There are two co-primary endpoints: To assess the change in atopic ezcema severity between baseline visit and 12 weeks of treatment with Methotrexate or Ciclosporin treatment, using the 0SCORAD index and Time to first significant flare up during the 24 weeks after the end of treatment with either Methotrexate or Ciclosporin.
Critère d'inclusion
- severe atopic ezcema